Last updated 2026-07-26
- Raised $54k grant, Jan 2019
- Raised Series A led by KCK Medtech, May 2023
- Raised grant, Apr 2019
Total raised
$111K
Last: Undisclosed Round 2023-05
Stage
Series A
Founded
2016
Headcount
30
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences
About
Revamp Medical is a privately held clinical-stage medical technology company committed to developing solutions for Heart Failure congestion management. The company's Doraya™ device is a catheter-delivered flow modulator, placed temporarily in the inferior vena cava just below the renal veins. Doraya is designed to lower central venous pressure (CVP) and renal afterload, thereby improving renal filtration and responsiveness to diuretics, aiming to improve diuretic efficacy and progressive decongestion in acute heart failure patients.
Funding history · 3 rounds · $111K total
2023-05
A Round
Undisclosed
conduit+reconcile
★ KCK Medtech
2019-04
Grant
Undisclosed
conduit+reconcile
2019-01
Grant
$54K
conduit+reconcile
Headcount over time
From 6 (2018-06) to 14 (2026-01) · +8 (+133%) · 13 points · source: Finder history + radar grounding
Q&A
- What is Revamp Medical's primary focus?
- Revamp Medical is a clinical-stage medical technology company developing solutions for Heart Failure congestion management, specifically a catheter-based device called Doraya™.
- When was Revamp Medical founded?
- Revamp Medical was founded in 2016.
- How many employees does Revamp Medical have?
- Revamp Medical has 11-50 employees.
- Which investor led Revamp Medical's Series A funding round?
- KCK Medtech led Revamp Medical's Series A funding round in May 2023.
- What is the total amount of funding Revamp Medical has raised?
- Revamp Medical has raised a total of $111,000 USD.
- What is the purpose of Revamp Medical's Doraya™ device?
- The Doraya™ device is a catheter-delivered flow modulator designed to lower central venous pressure (CVP) and renal afterload, aiming to improve diuretic efficacy and progressive decongestion in acute heart failure patients.
- Did Revamp Medical receive any significant regulatory designations for its product?
- Yes, in July 2020, Revamp Medical's DORAYA acute heart failure catheter received FDA breakthrough device designation.
- Who are the co-founders of Revamp Medical?
- The co-founders of Revamp Medical are Lihu Avitov and Rafi Benary.
Team · 2
Lihu Avitov
Founder · Co-founder
Rafi Benary
Founder · Co-founder & CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
heart-failurehealthcare-providersmedical-devicessurgerydoctorshospitalscatheterscardiologymedical-technologiestreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | revampmedical.com |
|---|---|
| linkedin.com/company/12953721 |
Identifiers & details
| Legal name | Revamp Medical Inc. |
|---|---|
| Founded | 2016 |
| Employees (exact) | 30 |
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | revampmedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515360378 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-12-21 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | מפי 5 נתניה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |